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Abstract  
 
 
 
 
 
Purpose 
The main objective of this study was to determine the preliminary Diagnostic 
Reference Levels (DRLs) in terms of Kerma Area Product (KAP) and fluoroscopy 
time (Tf) during Endoscopic Retrograde Cholangio-Pancreatography (ERCP) 
procedures. Additionally, an investigation was conducted to explore the statistical 
relation between KAP and Tf. 
 
Material - Methods 
Data from a set of 200 randomly selected patients treated in 4 large hospitals in 
Greece (50 patients per hospital) were analyzed in order to obtain preliminary 
Diagnostic Reference Levels (DRLs) for KAP and Tf during therapeutic ERCP 
procedures. Non-parametric statistic tests were performed in order to determine a 
statistically significant relation between KAP and Tf. 
 
Results 
The resulting third quartiles for KAP and Tf for hospitals (A, B, C and D) were found 
as followed: KAPA=10.7 Gy·cm2, TfA=4.9 min ; KAPB=7.5 Gy·cm2, TfB=5.0 min ; 
KAPC=19.0 Gy·cm2, TfC=7.3 min ;  KAPD=52.4 Gy·cm2 , TfD=15.8 min. The third 
quartiles, calculated for the total 200 cases sample, are: KAP=18.8 Gy·cm2 and 
Tf=8.2 min. For 3 out of 4 hospitals and for the total sample, p-values of statistical 
indices (correlation of KAP and Tf) are less than 0.001, while for the Hospital A p-
values are ranging from 0.07 to 0.09. Using curve fitting, we finally determine that the 
relation of Tf and KAP is deriving from a power equation (KAP=Tf1.282) with 
R2=0.85. 
 
Conclusion 
The suggested Preliminary DRLs (deriving from the third quartiles of the total 
sample) for Greece are: KAP=19 Gy·cm2 and Tf=8 min, while the relation between 
KAP and Tf is efficiently described by a power equation. 
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Introduction 
 
Endoscopic Retrograde Cholangio-Pancreatography (ERCP) is a commonly used 
procedure, which enables physicians to examine the pancreatic and bile ducts. An 
HQGRVFRSH LV LQVHUWHG WKURXJK PRXWK LQWR SDWLHQW¶V VWRPDFK DQG ILUVW SDUW RI
duodenum. In the duodenum a small opening is located and through the endoscope, a 
secondary tube is passed into that opening. Contrast material is injected and images 
are acquired by the use of x-rays, in order to study ducts of pancreas and liver [1].  
The steadily increasing use of fluoroscopy in ERCP technique has often raised 
concerns regarding the potential risks from the radiation exposure of patients [1-9].  
That is mainly due to the fact that ERCP is often performed outside radiological 
departments by operators with questionable knowledge and training on radiation 
protection and procedure optimization [10]. Diagnostic reference levels (DRLs) have 
been recommended by the Internal Commission of Radiological Protection (ICRP) as 
an advisory measure to improve optimization of patient protection, by identifying 
high or low patient dose levels which might not be justified on the basis of image 
quality requirements [11]. There is limited data on ERCP DRL in Europe [1-7,9] and 
and absence of national ERCP DRLs in Greece.  
The new Basic Safety Standards Directive (Council Directive 2013/59/Euratom) on 
the safe use of radiation in Europe underlines the immense importance of setting 
national DRLs especially in complex interventional procedures including ERCP. The 
main aim of the current study was to measure Kerma Area Product (KAP) and 
fluoroscopy time (Tf) in representative centers in Greece performing ERCP and 
determine national preliminary DRLs for ERCP. The secondary target was to 
investigate possible statistically significant relation between the measured KAP and 
Tf and if so, to determine which is the best equation to describe it.  
 
 
 
Materials and Methods 
 
Patient data were randomly collected from 4 large hospitals performing therapeutic 
ERCP procedures for a variety of both benign and malignant hepatobiliary and 
pancreatic diseases. Written informed consent was obtained from all patients in 
accordance with guidelines set forth by the institutional boards of the hospitals. All 
patients were sedated and positioned on the X-ray unit table in a semi-prone position 
that was kept fixed throughout the whole procedure. Therefore, the typical exposed 
anatomical area (given that the patients have deviations in height, weight, BMI etc.) 
was maintained for the total sample.  
Technical data collected for each patient included patient radiation dose expressed in 
terms Kerma Area Product (KAP measured in Gy·cm2) and fluoroscopy time (Tf 
measured in minutes). Data were collected for a total number of 200 ERCPs (50 cases 
for each hospital in order to have statistically balanced sets of data), performed by 
gastroenterologists with more than 10 years of experience in ERCP procedures. All 
endoscopists shared similar competence, efficiency and expertise in the field. There 
was no digression from standard unit practice in terms of the procedures performed. 
The X-ray machines were controlled by the radiographer according to the indications 
of the endoscopist. 
Different equipment was used in each hospital for ERCP procedures (Table 1). In 
Hospital A, a conventional radiology unit with over-couch X-ray tube (OC) was used. 
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In Hospital B, a conventional radiology unit but with under-couch X-ray tube (UC) 
was used. In Hospitals C and D, a C-arm unit (CA) and a digital angiography unit 
(AG) were used respectively. All X-ray machines had a KAP meter installed in the X-
ray tube housing. The meter was calibrated according to the method summarized in 
WKH µQDWLRQDO SURWRFRO IRU SDWLHQW GRVH PHDVXUHPHQWV LQ GLDJQRVWLF UDGLRORJ\¶ 
developed by the National Radiological Protection Board [12]. 
For each hospital the following statistics were calculated for KAP and Tf: a) Average, 
b) Median, c) Standard Deviation (SD), d) Coefficient of Variation (SD/Average), e) 
First Quartile and f) Third Quartile. Then the above statistics were calculated again 
for the total of 200-patients sample. These results were compared with the recent 
international literature for further investigation.  
To extract the suggested national preliminary DRLs all 200 cases were considered as 
one sample. For this set of data the third quartiles for KAP and Tf were extracted and 
considered as DLRs. 
Using non-parametric statistic indices 6SHDUPDQDQG.HQGDOO¶VWDX%S-values in 2-
tailed correlation) a possible statistically significant relation between KAP and Tf for 
each hospital and for the total sample was investigated. Investigating that relation, a 
benchmark of fit was performed for a total of 10 different types of equations (linear, 
Logarithmic, Inverse, Quadratic, Cubic, Compound, Power, S, Growth and 
Exponential). The fit that would present the highest value of R2 was considered to be 
the most appropriate to describe the relation between KAP and Tf.  
 
 
 
 
Results 
 
The resulting statistics (Average, Standard Deviation, Median, Range, Coefficient of 
Variation, First Quartile and Third Quartile) for KAP and Tf, both for each hospital 
independently and for the total sample, are stored in Table 2. Since data were not 
following the normal distribution, non parametric methods were used. 
The resulting third quartiles for KAP and Tf for each one of the hospitals (stored in 
Table 2 as Third Quartiles) are as follows: KAPA=10.7 Gy·cm2 , TfA=4.9 min ; 
KAPB=7.5 Gy·cm2 , TfB=5.0 min ; KAPC=19.0  Gy·cm2 , TfC=7.3 min ;  KAPD=52.4 
Gy·cm2 , TfD=15.8 min. Regarding the 200 cases as one sample the third quartiles for 
KAP and Tf (Table 2), which will provide the national suggested preliminary DRLs 
for Greece, are:  KAP=18.8 Gy·cm2 and Tf=8.2 min.  
Furthermore, for the 3 out of 4 hosSLWDOV6SHDUPDQDQG.HQGDOO¶VWDX%S-values are 
less than 0.001 while for the Hospital A p-values are ranging from 0.07 to 0.09 (data 
along with the correlation coefficients stored in Table 4). As for the total sample of 
200 cases, both Spearman and KendaOO¶VWDX%S-values are less than 0.001, stating we 
are sure at 99% significance level that there is a relation between KAP and Tf. For the 
determination of the most proper equation to describe that relation, a series of 
benchmarks were used and the possible fit curves are presented in figure 1. In contrast 
to what expected, the linear equation does not provide the best fit (R2=0.608); instead 
the best fit is derived from a power equation: KAP=Tf1.282 (R2=0.845). 
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Discussion 
 
This is an initial study for the description of preliminary DRLs for ERCP procedures 
in general. For that reason, we used 50 therapeutic ERCPs cases from each of 4 
participant hospitals. In order to provide a credible comparison, we chose to 
benchmark our results with studies based on sufficient number of cases (10 cases or 
more). Statistical values of KAP and Tf chosen to be used for comparison are: 
Average, Median and Third Quartile, because they are the mostly commonly used in 
current literature. The comparison data are shown in Table 3. 
Diagnostic ERCPs (diag) of current literature [3,4] show that average values for KAP 
and Tf are approximately 20 Gy·cm2 and 2 min respectively. For therapeutic ERCPs 
(ther) average values for KAP and Tf are approximately 44 Gy·cm2 and 4.2 min 
respectively [2,5,10]. The above results confirm that therapeutic ERCPs average 
fluoroscopy time and KAP are two times greater than the respective values for 
diagnostic ERCPs. The average values for KAP and Tf of this work (therapeutic 
cases) are 15.5 Gy·cm2 and 6.4 min respectively, significantly lower for KAP in 
comparison even with the purely diagnostic studies. NRPB ±W14 [9] is the only study 
big study that involves a mixture of diagnostic and therapeutic ERCPs (mixed). 
NRPB ±W14 states that for a mixed cases sample greater than 4500 patients, the 
average values for KAP and Tf are 15.5 Gy·cm2 and 4.4 min - exactly the same 
average KAP with the one of our study. The comparison for the average values of 
KAP and Tf is visualized in figure 2. 
The average of median values for KAP and Tf in therapeutic ERCPs [2,5,10] are 
25.45 Gy·cm2 and 3.5 min, while in our study are 7.8 Gy·cm2 and 4.4 min 
respectively. In comparison with the respective median values from NRPB ±W14 
(14.1 Gy·cm2 and 4.2 min), this work produces the half value of median KAP in 
approximately the same median time. The comparison for the median values of KAP 
and Tf is visualized in figure 3. 
Finally, therapeutic ERCPs  [2,5] approximately produce values for third quartiles for 
KAP=54.6 Gy·cm2 and Tf=7.7 min, while in mixed cases scenario (NRPB ±W14) the 
respective values are KAP=19 Gy·cm2 and Tf=5.3 min. For the current study, the 
third quartiles of the total sample are KAP=18.8 Gy·cm2 and Tf=8.2 min. The above 
confirms that in term of KAP third quartile for the total sample, this study produces 
nearly identical results with NRPB±W14, while the Tf third quartile value is higher 
for Greece. The comparison for the third quartiles of KAP and Tf is visualized in 
figure 4. 
Regarding the description of the KAP and Tf correlation by a power equation rather 
than a linear one, we must recall that the data set includes the deviation of different 
equipment and methods applied in each of the 4 hospitals, and is limited to 200 cases. 
Even the most recent studies [13] state that the relation of KAP and Tf is described by 
a linear equation, given that all cases were treated with unchanged machinery. Since 
DRLs should not be related with specific method, equipment or patient, the relation of 
KAP and Tf is possible to derive from a power equation. The huge difference in the 
R2 for the linear and power equation models is mainly caused by the equipment used 
in each hospital (refer to medians of KAP and Tf for each hospital in Table 2).  
Any benchmark relating the equipment used in the 4 participating hospitals, KAP, Tf, 
patient characteristics and image quality is out of the scope of this study. DRLs, as 
already mentioned in the introduction, are advisory measures to improve optimization 
of patient protection and should be highly considered by hospitals in Greece 
performing therapeutic ERCPs with parameters above the suggested levels. 
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Conclusion 
 
This study is a first approach for national DLRs for therapeutic ERCP procedures. 
The suggested preliminary DRLs by this work (summarizing Table 5) are: KAP=19 
Gy·cm2 and Tf=8 min (calculated for KAP and Tf of the total sample). Adding to the 
above and according to our sample we can be confident that there is a relation 
between KAP and Tf, which is most appropriately described by a power equation.  
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Table 1 
 
 
Hospital X-ray machine Type X-ray tube above/under table 
A Philips Essenta Conventional up 
B Philips Easy Diagnost Conventional down 
C Philips BV Pulsera C-arm down 
D Siemens Axiom Artis Angiography down 
Table 1 - Equipment used in each of the 4 participant hospitals for ERCP procedures 
 
Table 2 
 
 
TfA 
(min) 
KAPA 
(Gy·cm2) 
TfB 
(min) 
KAPB 
(Gy·cm2) 
TfC 
(min) 
KAPC 
(Gy·cm2) 
TfD 
(min) 
KAPD 
(Gy·cm2) 
Tf 
(min) 
KAP 
(Gy·cm2) 
Average 4.4 8.5 4.2 6.1 6.4 13.2 10.5 34.3 6.4 15.5 
SD 4.2 15.4 4.4 6.1 6.2 8.7 7.3 28.5 6.2 20.4 
Median 3.3 3.1 3.1 4.6 4.9 9.3 9.2 25.7 4.4 7.8 
Range (0.2-18) 
(0.4-
104.3) 
(0.5-
26.8) 
(1.0-
41.3) 
(0.1-
41.7) 
(1.7-
49.0) 
(1-
32.7) 
(2.3-
130.0) 
(0.1-
41.7) 
(0.4-
130.2) 
Coefficient of 
Variation 95% 182% 106% 100% 98% 66% 70% 83% 98% 131% 
First Quartile 1.7 2.0 1.7 3.1 3.4 6.6 4.8 15.5 2.3 3.7 
Third 
Quartile 4.9 10.7 5.0 7.5 7.3 19.0 15.8 52.4 8.2 18.8 
Table 2 - Statistical Analysis for each hospital (A, B, C and D) and total sample for ERCP procedures 
 
 
Table 3 
 
  
  
Larkin et Al. [3] (diag) Olgar et Al. [4] (diag) Tsalafoutas et Al. [2]  (ther) 
Tf 
(min) KAP (Gy·cm
2) Tf (min) KAP (Gy·cm
2) Tf (min) KAP (Gy·cm
2) 
Average 2.3 13.5 1.9 26.2 6.0 41.8 
Median     4 27.9 
Third 
Quartile     7.1 48,9 
  
  
IAEA 1641 Part.E [10]  
(ther) 
IAEA 1641 Part.F [10] 
(ther) NRPB W14 [9] (Mixed) 
Tf 
(min) KAP (Gy·cm
2) Tf (min) KAP (Gy·cm
2) Tf (min) KAP (Gy·cm
2) 
Average 6.0 20.0 3.7 65.3 4.4 15.5 
Median 3.3 11.1 1.7 23.6 4.2 14.1 
Third 
Quartile     5.3 19.0 
  
  
Buls et Al. [5] (ther) Averages of 4 Hospitals Total Sample 
Tf 
(min) KAP (Gy·cm
2) Tf (min) KAP (Gy·cm
2) Tf (min) KAP (Gy·cm
2) 
Average 6 49.9 6.4 15.5 6.4 15.5 
Median 5.2 39 5.1 10.7 4.4 7.8 
Third 
Quartile 8.3 60.3 8.3 22.4 8.2 18.8 
Table 3 - Results comparison with diagnostic, therapeutic and mixed cases data of the current 
literature on ERCP procedures 
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Table 4 
 
 
 P-value Spearman Correlation Coefficient ȡ P-value Kendall Correlation Coefficient Ĳ 
Hospital A 0.068 0.260 0.077 0.174 
Hospital B 0.000 0.922 0.000 0.778 
Hospital C 0.000 0.788 0.000 0.588 
Hospital D 0.000 0.654 0.000 0.508 
Total Sample 0.000 0.692 0.000 0.533 
Table 4 - Spearman and Kendall correlation p-values for KAP and Tf for ERCP procedures 
 
 
Table 5 
 
 KAP (Gy·cm2) Tf (min) 
 Preliminary DRL 19 8 
Average  16 6 
SD  20 6 
Median  8 4 
Range  0 - 42 0 - 130 
Table 5 - ERCP DRLs for KAP and Tf for 200 ERCP procedures in Greece  
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